APA (7th ed.) Citation

Jennemann, R., & Sandhoff, R. (2025). The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis. International Journal of Molecular Sciences, 26(19), 9811. https://doi.org/10.3390/ijms26199811

Chicago Style (17th ed.) Citation

Jennemann, Richard, and Roger Sandhoff. "The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis." International Journal of Molecular Sciences 26, no. 19 (2025): 9811. https://doi.org/10.3390/ijms26199811.

MLA (9th ed.) Citation

Jennemann, Richard, and Roger Sandhoff. "The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis." International Journal of Molecular Sciences, vol. 26, no. 19, 2025, p. 9811, https://doi.org/10.3390/ijms26199811.